Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOXJean‐François Emile, Yves Humblet, Catherine Julié et al.|European Journal of Cancer|2017Cited by 47
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trialZoltán Bánki, Janine Kimpel, Alba Grifoni et al.|EBioMedicine|2022Cited by 38
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial datasetJosef Thaler, Mohamed-Ayman Zawadi, Richard Greil et al.|Annals of Oncology|2015Cited by 4